CELU.NASDAQCelularity INC

Form 4: Celularity Inc. Executive Stephen Brigido Reports Stock Transaction

Sentiment:

SEC Form 4 Filing


Stephen Brigido, President of Functional Regeneration at Celularity Inc., reports the withholding of shares to cover tax obligations related to vested restricted stock units.

Summary

  • On April 13, 2024, Stephen Brigido, President of Functional Regeneration at Celularity Inc., had shares withheld by the issuer to cover tax obligations related to the vesting of restricted stock units (RSUs).
  • A total of 268 shares of Class A Common Stock were withheld at a price of $4.11 per share.
  • Following the transaction, Brigido beneficially owns 19,472 shares, including 18,920 shares underlying RSUs granted under the company's 2021 Equity Incentive Plan.
  • The reported securities numbers have been adjusted to reflect a 1-for-10 reverse stock split that occurred on February 29, 2024.

Sentiment

Score: 5

Explanation: This is a neutral report on a routine stock transaction related to tax obligations. It doesn't indicate positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It's a standard practice for executives to have shares withheld to cover tax obligations when RSUs vest.

Key Dates

DateDescription
February 29, 2024Celularity Inc. effected a 1-for-10 reverse stock split on its Common Stock.
April 13, 2024Stephen Brigido had shares withheld by Celularity Inc. to satisfy tax obligations related to vested RSUs.
April 16, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.